4.7 Editorial Material

The reset button revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients

Journal

Publisher

SPRINGER
DOI: 10.1007/s00259-017-3649-9

Keywords

-

Funding

  1. SanofiGenzyme
  2. Henning
  3. Cancer Research UK [16464] Funding Source: researchfish

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available